Clinitech Laboratory Ltd

Clinitech Laboratory Ltd has announced a Board of Directors meeting scheduled for November 13, 2026, via video conference. The primary agenda items include the consideration and approval of the Un-Audited Financial Results for the half-year ended September 30, 2026, along with the Limited Review Report. The board will also take note of the Internal Audit Report for the same period. In compliance with SEBI regulations, the trading window has been closed from October 1, 2026, and will reopen 48 hours after the financial results announcement.

Clinitech Laboratory Ltd has announced the closure of its trading window for designated persons, including directors, promoters, and their immediate relatives, from October 1, 2026. This closure is in anticipation of the board meeting to approve the unaudited standalone and consolidated financial results for the half-year ended September 30, 2026. The trading window will reopen 48 hours after the declaration of these financial results. The specific date of the board meeting will be communicated in due course.

Clinitech Laboratory Ltd has announced its Annual General Meeting (AGM) will be held on September 24, 2026, at 11:30 AM IST via video conferencing. The company has also attached its Annual Report, which includes the Notice of AGM and various annexures. The Register of Members and Share Transfer Books will be closed from September 18 to September 24, 2026, inclusive, for the purpose of the AGM. The report details the company's board of directors, executive management, auditors, bankers, and registered office information.

Clinitech Laboratory Ltd has announced the date for its 16th Annual General Meeting (AGM) to be held on September 24, 2026. The company has also set the book closure dates from September 18, 2026, to September 24, 2026, inclusive, for the purpose of the AGM. The AGM will be conducted via video conferencing. Additionally, the e-voting period is scheduled from September 21 to September 23, 2026, with a cut-off date of September 17, 2026.

Clinitech Laboratory Ltd has filed its Annual Report for the Financial Year 2025-26, along with the Notice of the Annual General Meeting (AGM) and all associated annexures. The report details the company's performance and includes sections on general information, management notes, board reports, management discussion and analysis, remuneration particulars, financial statements (standalone and consolidated), auditor reports, and secretarial audit reports. The Register of Members and Share Transfer Books will be closed from September 18 to September 24, 2026, for the purpose of the AGM.

Clinitech Laboratory Ltd's Board of Directors convened on August 17, 2026, approving key corporate actions. The meeting saw the approval of a director retiring by rotation, the Board's report for FY 2025-26 along with its annexures, and the notice for the 16th Annual General Meeting. The dates for Book Closure for the AGM were finalized, and Mr. Deep Shukla was appointed as the scrutinizer for the voting process.

Clinitech Laboratory Ltd has announced a Board of Directors meeting scheduled for August 17, 2026, to be held via video conference at 11:30 AM IST. The agenda includes approving the appointment of a director retiring by rotation, the Board's report for FY 2025-26, and the notice for the 16th Annual General Meeting, including book closure dates. The company will also finalize the appointment of Mr. Deep Shukla as a scrutinizer for the AGM voting process. This meeting is convened as per SEBI (LODR) Regulations, 2015.

Clinitech Laboratory Limited has filed a statement confirming no deviation or variation in the utilization of funds raised through its Public Issue (IPO) as of March 31, 2026. The company raised ₹578.30 Lakhs on July 30, 2024. Funds were primarily allocated for the expansion of diagnostic centres (₹498.67 Lakhs), general corporate purposes (₹41.33 Lakhs), and issue-related expenses (₹38.30 Lakhs). As of the reporting quarter, ₹528.30 Lakhs has been utilized, with the company asserting full adherence to the original objects of the issue.

CLINITECH LABORATORY LIMITED's Board of Directors met on May 28, 2026, and approved the Audited Standalone & Consolidated Financial Results for the half year and financial year ended March 31, 2026. The Board also took note of the Internal Audit Report for the half year ended March 31, 2026, and related party transactions for FY26, while approving estimated related party transactions for FY2026-27. The Statutory Auditors, M/s Kale Malde & Co., issued an "unmodified opinion" on the financial results.

CLINITECH LABORATORY LIMITED's Board of Directors met on May 28, 2026, to approve the Audited Standalone & Consolidated Financial Results for the half year and financial year ended March 31, 2026. The Board also took note of the Internal Audit Report for the half year ended March 31, 2026, and reviewed related party transactions for FY 2025-26, approving estimated transactions for FY 2026-27. The Statutory Auditors, M/s Kale Malde & Co., issued an "unmodified opinion" on the financial statements. The company also enclosed a certificate regarding the utilization of issue proceeds.